Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A Systematic Review and Meta-Analysis

Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A Systematic Review and Meta-Analysis

Inhibitors of the IL-6 signaling pathway, such as tocilizumab, are frequently administered for the treatment of immune diseases, e.g., rheumatoid arthritis and multicentric Castleman’s disease. The aim of this systematic review and meta-analysis was to ascertain the effects of IL-6 pathway inhibitor...

Full description

Bibliographic Details
Main Authors: Olivia Patsalos, Bethan Dalton, Hubertus Himmerich
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
IL-6
tocilizumab
siltuximab
weight
BMI
spondyloarthritis
Online Access:https://www.mdpi.com/1422-0067/21/17/6290

Similar Items

Similar Items